Defining multiplicity of vector uptake in transfected Plasmodium parasites


Change log
Authors
Carrasquilla, Manuela  ORCID logo  https://orcid.org/0000-0002-7953-4376
Adjalley, Sophie 
Sanderson, Theo 
Marin-Menendez, Alejandro 
Coyle, Rachael 
Abstract

Abstract: The recurrent emergence of drug resistance in Plasmodium falciparum increases the urgency to genetically validate drug resistance mechanisms and identify new targets. Reverse genetics have facilitated genome-scale knockout screens in Plasmodium berghei and Toxoplasma gondii, in which pooled transfections of multiple vectors were critical to increasing scale and throughput. These approaches have not yet been implemented in human malaria species such as P. falciparum and P. knowlesi, in part because the extent to which pooled transfections can be performed in these species remains to be evaluated. Here we use next-generation sequencing to quantitate uptake of a pool of 94 barcoded vectors. The distribution of vector acquisition allowed us to estimate the number of barcodes and DNA molecules taken up by the parasite population. Dilution cloning of P. falciparum transfectants showed that individual clones possess as many as seven episomal barcodes, revealing that an intake of multiple vectors is a frequent event despite the inefficient transfection efficiency. Transfection of three spectrally-distinct fluorescent reporters allowed us to evaluate different transfection methods and revealed that schizont-stage transfection limited the tendency for parasites to take up multiple vectors. In contrast to P. falciparum, we observed that the higher transfection efficiency of P. knowlesi resulted in near complete representation of the library. These findings have important implications for how reverse genetics can be scaled in culturable Plasmodium species.

Description
Keywords
Article, /631, /631/326, /631/326/417, /631/326/417/2551, article
Journal Title
Scientific Reports
Conference Name
Journal ISSN
2045-2322
Volume Title
10
Publisher
Nature Publishing Group UK
Sponsorship
Wellcome Trust (Wellcome) (206194)